News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare Conferences

BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:  www.arraybiopharma.com.   

Event:    

Stifel 2016 Healthcare Conference

Date:   

Tuesday, November 15, 2016

Time:    

10:15 a.m.  Eastern Standard Time



Event:                 

Jefferies 2016 Global Healthcare Conference

Date:               

Thursday, November 17, 2016

Time:            

5:20 p.m.  Greenwich Mean Time

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-stifel-2016-healthcare-and-jefferies-2016-global-healthcare-conferences-300359249.html

SOURCE Array BioPharma Inc.